GC Ventures Co., Ltd. (GCV) — a wholly-owned subsidiary of PTT Global Chemical PCL (GC), a leading global chemical company for better living — has invested €4.35 million in the European Circular Bioeconomy Fund (ECBF). This move is part of GC’s “Together to Net Zero” roadmap to improve the quality of life for all with a transition to a low-carbon business. By achieving net-zero emissions throughout its value chain, GC will further reinforce its “Chemistry for Better Living” commitment.

GC is aware of the multitude of issues and challenges facing its business and the environment, including climate change, public health, digital disruption, and waste management. GC has founded GCV to innovate solutions to these challenges. Through strategical investments and partnerships with venture capital firms and start-ups around the world, GCV not only provides solutions to the problems, but also prepares GC for expansion. It invests in venture capital funds to foster exponential innovation and business growth.

GCV has offices in Bangkok, Thailand, and in Massachusetts, USA. It focuses on the pursuit of technology, serious investment opportunities and makes corporate venture capital investments through GCV and GCVA (GC Ventures America Corporation).

Initiated in 2020, ECBF is a European Union fund located in Luxembourg, with Hauck & Aufhäuser Funds Services SA as its alternative investment fund manager (AIFM) and ECBF Management GmbH as its experienced circular bioeconomy consulting team. ECBF’s vision is to drive the transition from a fossil economy to a bioeconomy, aiming to fill the financial gap in the European bioeconomy, especially in terms of Europe’s leading expertise in renewable technologies. Private investments in this fund now total more than €300 million, financing growing firms in Europe’s bio-economy and circular bioeconomy that meet the most stringent levels of ESG criteria.